beta

HROWL

Harrow Inc

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. its products portfolio includes topical eye drop drug candidates, including surf-100 and surf-200; surf-300, an oral capsule for treating patients suffering from ocular surface diseases, and ded signs and symptoms; klarity drops to protect and rehabilitate the ocular surface pathology for patients with ded; melt-100, a drug that is administered sublingually for conscious sedation during cataract surgery; may-66 that is used for the treatment of symptoms associated with peyronie's diseas

Market Cap: 397 Million

Primary Exchange: NASDAQ

Website: harrowinc.com

Shares Outstanding: 35.1 Million

Float: 0

Dividend: 2.085927006398233 (0.09%)

Beta: 0.0618378915782992

Sector: Manufacturing

Industry: Pharmaceutical Preparation Manufacturing

Ethical Flags

Longest drawdown: 672 trading days

From: 2022-01-11 To: 2024-03-07

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
2021-07-14 2021-08-02 2021-07-15 0.604948 Cash
2021-10-14 2021-11-01 2021-10-15 0.539062 Cash
2022-01-13 2022-01-31 2022-01-15 0.539062 Cash
2022-04-13 2022-04-30 2022-04-15 0.533073 Cash
2022-07-14 2022-07-31 2022-07-15 0.539062 Cash
2022-10-13 2022-10-31 2022-10-15 0.539062 Cash
2023-01-12 2023-01-31 2023-01-15 0.539062 Cash
2023-04-13 2023-04-30 2023-04-15 0.539062 Cash
2023-07-13 2023-07-31 2023-07-15 0.539062 Cash
2023-10-12 2023-10-31 2023-10-15 0.539062 Cash
2024-01-11 2024-01-31 2024-01-15 0.539063 Cash
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud